• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌碳水化合物如何影响适应性免疫系统。

How bacterial carbohydrates influence the adaptive immune system.

机构信息

Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Annu Rev Immunol. 2010;28:107-30. doi: 10.1146/annurev-immunol-030409-101159.

DOI:10.1146/annurev-immunol-030409-101159
PMID:19968562
Abstract

The capsular polysaccharides (CPSs) of most pathogenic bacteria are T cell-independent antigens whose conjugation to carrier proteins evokes a carbohydrate-specific response eliciting T cell help. However, certain bacterial CPSs, known as zwitterionic polysaccharides (ZPSs), activate the adaptive immune system through processing by antigen-presenting cells and presentation by the major histocompatibility complex class II pathway to CD4(+) T cells. This discovery was the first mechanistic insight into how carbohydrates-a class of biological molecules previously thought to be T cell independent-can in fact activate T cells. Through their ability to activate CD4(+) T cells, ZPSs direct the cellular and physical maturation of the developing immune system. In this review, we explore the still-enigmatic relations between CPSs and the adaptive immune machinery at the cellular and molecular levels, and we discuss how new insights into the biological impact of ZPSs expand our concepts of the role of carbohydrates in microbial interactions with the adaptive immune system.

摘要

大多数病原菌的荚膜多糖(CPS)是 T 细胞非依赖型抗原,与载体蛋白结合可引发针对碳水化合物的特异性反应,从而募集 T 细胞辅助。然而,某些被称为两性离子多糖(ZPS)的细菌 CPS 通过抗原呈递细胞的加工以及主要组织相容性复合体 II 途径呈递至 CD4+T 细胞,激活适应性免疫系统。这一发现首次揭示了碳水化合物(一类曾被认为是 T 细胞非依赖型的生物分子)实际上如何激活 T 细胞的机制。通过激活 CD4+T 细胞,ZPS 指导着正在发育的免疫系统的细胞和物理成熟。在这篇综述中,我们探讨了 CPS 与适应性免疫机制在细胞和分子水平上的仍然神秘的关系,并讨论了对 ZPS 生物学影响的新认识如何扩展我们对碳水化合物在微生物与适应性免疫系统相互作用中作用的概念。

相似文献

1
How bacterial carbohydrates influence the adaptive immune system.细菌碳水化合物如何影响适应性免疫系统。
Annu Rev Immunol. 2010;28:107-30. doi: 10.1146/annurev-immunol-030409-101159.
2
Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.细菌抗原递呈系统:细菌抗原的吞噬加工,用于MHC-I和MHC-II呈递给T细胞。
Behring Inst Mitt. 1997 Feb(98):197-211.
3
The cellular basis of the immune response to conjugate vaccines.对结合疫苗免疫反应的细胞基础。
Contrib Microbiol Immunol. 1989;10:18-47.
4
Carbohydrates and T cells: a sweet twosome.碳水化合物和 T 细胞:一对甜蜜的组合。
Semin Immunol. 2013 Apr;25(2):146-51. doi: 10.1016/j.smim.2013.05.005. Epub 2013 Jun 10.
5
Interleukin-6 is essential for zwitterionic polysaccharide-mediated abscess formation.白细胞介素-6 对于两性离子多糖介导的脓肿形成是必不可少的。
Innate Immun. 2010 Oct;16(5):310-21. doi: 10.1177/1753425909346974. Epub 2009 Nov 6.
6
New generation vaccines: does antibody play a directional role in antigen-processing?新一代疫苗:抗体在抗原加工过程中起定向作用吗?
Am J Trop Med Hyg. 1991 Apr;44(4 Pt 2):28-33.
7
Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants.人类对多糖抗原的免疫反应:婴儿细菌多糖疫苗分析
Adv Pediatr. 1985;32:139-58.
8
Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens.两性离子荚膜多糖:新型MHCII依赖性抗原。
Cell Microbiol. 2005 Oct;7(10):1398-403. doi: 10.1111/j.1462-5822.2005.00591.x.
9
The love-hate relationship between bacterial polysaccharides and the host immune system.细菌多糖与宿主免疫系统之间的爱恨关系。
Nat Rev Immunol. 2006 Nov;6(11):849-58. doi: 10.1038/nri1956. Epub 2006 Oct 6.
10
[Molecular basis for detection of infectious agents].[检测感染因子的分子基础]
Schweiz Med Wochenschr. 1996 Feb 17;126(7):246-54.

引用本文的文献

1
Evidence of a novel sublineage of in elephants from zoo populations in Germany.来自德国动物园大象种群中一种新型亚谱系的证据。
Microb Genom. 2025 Sep;11(9). doi: 10.1099/mgen.0.001489.
2
Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives.用于疫苗开发的生物工程外膜囊泡:策略、进展与展望
Vaccines (Basel). 2025 Jul 20;13(7):767. doi: 10.3390/vaccines13070767.
3
Evaluation of capsule polysaccharide (CPS)-specific antibodies for broad recognition of prominent multidrug-resistant .
评估用于广泛识别主要多重耐药菌的荚膜多糖(CPS)特异性抗体。
Microbiol Spectr. 2025 Jul;13(7):e0333824. doi: 10.1128/spectrum.03338-24. Epub 2025 May 22.
4
Recent Progress in Developing Extracellular Vesicles as Nanovehicles to Deliver Carbohydrate-Based Therapeutics and Vaccines.开发细胞外囊泡作为纳米载体递送基于碳水化合物的治疗药物和疫苗的最新进展。
Vaccines (Basel). 2025 Mar 7;13(3):285. doi: 10.3390/vaccines13030285.
5
A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model.一种基于佐剂和铁蛋白纳米笼的联合粘膜疫苗可在小鼠模型中诱导针对肺炎链球菌的保护性免疫反应。
Nat Commun. 2025 Mar 24;16(1):2871. doi: 10.1038/s41467-025-58115-8.
6
Total synthesis of a structurally complex zwitterionic hexasaccharide repeating unit of polysaccharide B from Bacteroides fragilis via one-pot glycosylation.通过一锅法糖基化反应全合成脆弱拟杆菌多糖B结构复杂的两性离子六糖重复单元。
Commun Chem. 2024 Sep 12;7(1):204. doi: 10.1038/s42004-024-01296-y.
7
The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer.T 细胞介导的免疫对预防疫苗可预防疾病的贡献:简介。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2395679. doi: 10.1080/21645515.2024.2395679. Epub 2024 Aug 29.
8
Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines.使用表面免疫原性蛋白作为载体蛋白,针对B族链球菌聚糖结合疫苗候选物引发针对多种血清型的保护性抗体。
Vaccines (Basel). 2024 May 24;12(6):573. doi: 10.3390/vaccines12060573.
9
K2 capsular polysaccharide degradation by a bacteriophage depolymerase does not require trimer formation.噬菌体解聚酶对K2荚膜多糖的降解不需要三聚体形成。
mBio. 2024 Mar 13;15(3):e0351923. doi: 10.1128/mbio.03519-23. Epub 2024 Feb 13.
10
Mechanisms of Formation of Antibodies against Blood Group Antigens That Do Not Exist in the Body.体内不存在的血型抗原抗体形成机制。
Int J Mol Sci. 2023 Oct 10;24(20):15044. doi: 10.3390/ijms242015044.